Atrium

Increasing Cases of COVID-19 to Boost the Growth of Global Left Atrial Appendage Closure Devices Market in Pandemic Times - Exclusive Report [190 pages] by Research Dive

Retrieved on: 
Friday, August 21, 2020
Articles, Atrial appendage, Health, Impact of the COVID-19 pandemic, COVID-19 pandemic, Infectious diseases, Atrium, Auricular appendage

COVID-19 Impact on Left Atrial Appendage Closure Devices Market Report Highlights:

Key Points: 
  • COVID-19 Impact on Left Atrial Appendage Closure Devices Market Report Highlights:
    The CAGR of the left atrial appendage closure devices market as estimated before the outbreak of COVID-19 pandemic was 23.1% over the forecast period.
  • The market size of the left atrial appendage closure devices industry in 2020, as estimated before the COVID-19 pandemic began was $572.9 million.
  • The real-time market size in 2020, bearing the after-effects of the COVID-19 pandemic is $585.2 million
    Download Sample Analysis Report of Left Atrial Appendage Closure Devices Market: https://www.researchdive.com/covid-19-insights/362/left-atrial-appendage...
    The left atrial appendage closure devices industry is likely to experience a surge in the growth rate during the coronavirus pandemic.
  • As per the report , the global left atrial appendage closure devices market is anticipated to witness a tremendous growth even after the COVID-19 pandemic.

Increasing Cases of COVID-19 to Boost the Growth of Global Left Atrial Appendage Closure Devices Market in Pandemic Times - Exclusive Report [190 pages] by Research Dive

Retrieved on: 
Friday, August 21, 2020
Articles, Atrial appendage, Health, Impact of the COVID-19 pandemic, COVID-19 pandemic, Infectious diseases, Atrium, Auricular appendage

COVID-19 Impact on Left Atrial Appendage Closure Devices Market Report Highlights:

Key Points: 
  • COVID-19 Impact on Left Atrial Appendage Closure Devices Market Report Highlights:
    The CAGR of the left atrial appendage closure devices market as estimated before the outbreak of COVID-19 pandemic was 23.1% over the forecast period.
  • The market size of the left atrial appendage closure devices industry in 2020, as estimated before the COVID-19 pandemic began was $572.9 million.
  • The real-time market size in 2020, bearing the after-effects of the COVID-19 pandemic is $585.2 million
    Download Sample Analysis Report of Left Atrial Appendage Closure Devices Market: https://www.researchdive.com/covid-19-insights/362/left-atrial-appendage...
    The left atrial appendage closure devices industry is likely to experience a surge in the growth rate during the coronavirus pandemic.
  • As per the report , the global left atrial appendage closure devices market is anticipated to witness a tremendous growth even after the COVID-19 pandemic.

MemorialCare Long Beach Medical Center Now Offers WATCHMAN™ Left Atrial Appendage Closure Device for Patients Suffering from Atrial Fibrillation

Retrieved on: 
Tuesday, August 18, 2020
Branches of biology, Medicine, Interventional cardiology, Left atrial appendage occlusion, Cardiac arrhythmia, Clinical medicine, Atrial fibrillation, Atrial appendage, Atrium, Watchman, Anticoagulant, Long Beach Memorial Medical Center

LONG BEACH,Calif., Aug. 18, 2020 /PRNewswire/ -- The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is now offering the WATCHMAN Left Atrial Appendage Closure Device for patients with atrial fibrillation (AFib).

Key Points: 
  • LONG BEACH,Calif., Aug. 18, 2020 /PRNewswire/ -- The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is now offering the WATCHMAN Left Atrial Appendage Closure Device for patients with atrial fibrillation (AFib).
  • By closing off the left atrial appendage, the risk of stroke is reduced and, over time, patients can usually stop taking blood thinners.
  • For information regarding the availability of the WATCHMAN device at Long Beach Medical Center, call (562) 933-3370.
  • About MemorialCare Long Beach Medical Center:
    MemorialCare Long Beach Medical Center has been providing the community with compassionate, quality health care for more than 100 years.

AtriCure to Participate at Upcoming Investor Conferences

Retrieved on: 
Wednesday, July 29, 2020
Health, Medical devices, Hospitals, Surgery, Other Health, Clinical trials, Cardiology, Medical specialties, Surgery, Clinical medicine, Atrial fibrillation, Cardiac arrhythmia, RTT, Canaccord Genuity, Genuity, Atrial appendage, Laa, Cardiothoracic surgery, Atrium

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in several upcoming investor conferences.

Key Points: 
  • AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in several upcoming investor conferences.
  • AtriCure will be participating in the Guggenheim MedTech Disruptors Summit, scheduled to be held virtually August 10-11, 2020.
  • AtriCure will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11-13, 2020.
  • Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications.

AtriCure to Announce Second Quarter 2020 Financial Results

Retrieved on: 
Tuesday, July 7, 2020
Health, Medical devices, Hospitals, Surgery, Other Health, Clinical trials, Cardiology, Cardiac arrhythmia, Atrial fibrillation, RTT, Atrium, Laa

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2020 financial results on Tuesday, July 28, 2020.

Key Points: 
  • AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2020 financial results on Tuesday, July 28, 2020.
  • AtriCure will host a conference call at 4:30 p.m. Eastern Time on Tuesday, July 28, 2020 to discuss its second quarter 2020 financial results.
  • A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCures corporate website at ir.atricure.com .
  • Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications.

Atrium Health's Levine Children's Hospital Named a "Best Children's Hospital" for 13th Consecutive Year

Retrieved on: 
Tuesday, June 23, 2020
Software, Operating systems, Computing, Photo sharing, Social media, Healthcare in the United States, Atrium Health, Facebook, Atrium, Instagram, Charity care

One of a handful of sites nationwide with the ability to turn computer models into three-dimensional replicas of children's hearts.

Key Points: 
  • One of a handful of sites nationwide with the ability to turn computer models into three-dimensional replicas of children's hearts.
  • To learn more about the Levine Children's Hospital rankings, please visit levinechildrens.org/usnews and join our conversations by following us on Facebook , Instagram and Twitter.
  • With a commitment to every community it serves, Atrium Health seeks to improve health, elevate hope and advance healing for all.
  • Last year alone, Atrium Health provided more than $2.07 billion in free and uncompensated care and other community benefits.

Introducing The StopAfib.org Library Collection of No-Cost Videos for Atrial Fibrillation Patients

Retrieved on: 
Tuesday, June 16, 2020
Cardiac arrhythmia, RTT, Atrial fibrillation, Atrium, Library, AFIB Technology

DALLAS, June 16, 2020 /PRNewswire/ -- The StopAfib.org Library , an invaluable collection of video resources for people living with atrial fibrillation (afib), is now available at no cost.

Key Points: 
  • DALLAS, June 16, 2020 /PRNewswire/ -- The StopAfib.org Library , an invaluable collection of video resources for people living with atrial fibrillation (afib), is now available at no cost.
  • People can now create library accounts to access more than 70 hours' worth of carefully curated video content at no cost.
  • StopAfib.org was founded in 2007 by atrial fibrillation patients for afib patients.
  • To access a carefully curated collection of afib-related video materials, create a no-cost account at the StopAfib.org Library .

Atrium at Liberty Park Recognized for Memory Care in the News-Press Fourth Annual "Best of Cape Coral" Awards

Retrieved on: 
Monday, June 15, 2020
Health, Articles, Accessibility, Assisted living, Caregiving, Community nursing, Geriatrics, Cape Coral, Florida, Atrium

More than 250 businesses in the Cape Coral area representing a full range of categories were recognized during this live online presentation.

Key Points: 
  • More than 250 businesses in the Cape Coral area representing a full range of categories were recognized during this live online presentation.
  • "We are extremely proud of the recognition of Atrium earning a position on News-Press's "Best of Cape Coral" for Memory Care," says Gloria Hughes, Meridian Senior Living Vice President of Operations.
  • Thank you to all at the Atrium at Liberty Park"
    "I feel that the memory care staff always go above and beyond to provide terrific care for my mom," conveys Deb K. Memory Care resident family member.
  • About Atrium at Liberty Park:
    Atrium at Liberty Park features 130 supportive independent living, assisted living and memory care residences over 110,000 square feet.

AtriCure Reports First Quarter 2020 Financial Results

Retrieved on: 
Wednesday, April 29, 2020
Surgery, Medical devices, Finance, Hospitals, Clinical trials, Professional services, Cardiology, Other Health, Health, Cardiac arrhythmia, RTT, Atrial fibrillation, Atrium, Laa

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2020 financial results.

Key Points: 
  • AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2020 financial results.
  • Gross profit for the first quarter of 2020 was $38.9 million compared to $40.0 million for the first quarter of 2019.
  • Gross margin for the first quarter of 2020 decreased to 73.1% compared to 73.9% in the first quarter of 2019.
  • AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, April 29, 2020 to discuss its first quarter 2020 financial results.

Atrium Announces Atrium Works Brand to Answer New Workforce Needs

Retrieved on: 
Thursday, April 16, 2020
Professional services, Marketing, Communications, Human resources, Consulting, Public relations, Investor relations, Cardiff, Brand, Communication design, Graphic design, Product management, Atrium, Cardiff, Atrium

Atrium, a recognized leader in the Staffing and Workforce Solutions industry, launches their new brand, Atrium Works.

Key Points: 
  • Atrium, a recognized leader in the Staffing and Workforce Solutions industry, launches their new brand, Atrium Works.
  • The announcement comes as Atrium approaches its 25th year in business and at a time when innovation is needed most.
  • Adapting to the needs of the talent market while keeping people as the chief priority is exactly why Atrium was founded.
  • When it comes to finding and retaining talent, Atrium has the resources your business needs to succeed.